AI assistant
Sending…
BerGenBio — Director's Dealing 2022
Jan 7, 2022
3555_dirs_2022-01-07_255bcfbf-5079-4336-865e-134f139999eb.html
Director's Dealing
Open in viewerOpens in your device viewer
BERGENBIO - Mandatory notification of trade by Primary Insider
BERGENBIO - Mandatory notification of trade by Primary Insider
Bergen, Norway,7 January 2022?-BerGenBioASA (OSE: BGBIO) (the "Company"), has
been notified that Martin Olin, CEO and primary insider of BerGenBio ASA, has
bought 10,000 shares in BerGenBio ASA at an average price of NOK 20.03 per
share. After the transaction Mr. Olin holds 18,000 shares in BerGenBio ASA.
Please see the attached document for further details of the transaction.
Contact:
RuneSkeie, CFO,BerGenBioASA
This information issubject to the disclosure requirements pursuant to the EU
Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities
Trading Act.
More from BerGenBio
M&A Activity
2025
Oct 29
Delisting Announcement
2025
Oct 29
Capital/Financing Update
2025
Oct 28
M&A Activity
2025
Oct 24
Share Issue/Capital Change
2025
Sep 17
Share Issue/Capital Change
2025
Sep 17
Interim / Quarterly Report
2025
Aug 20
Earnings Release
2025
Aug 20
Share Issue/Capital Change
2025
Aug 5
Declaration of Voting Results & Voting Rights Announcements
2025
Aug 4